Genetic polymorphisms of CYP2D6 in Chinese mainland

被引:0
|
作者
Ji, L [1 ]
Pan, SX
Wu, JM
Marti-Jaun, J
Hersberger, M
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Med Lab, Wuhan 430022, Peoples R China
[2] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland
关键词
cytochrome P450-dependent monooxygenase; metabolizer; allele specific amplification PCR;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To observe the significant differences in the frequencies of the cytochrome P450 2D6 (CYP2D6) alleles in Chinese popoulations. Methods Tetra-primer polymerase chain reaction (PCR), allele specific amplification (ASA) PCR and multiplex long PCR were developed to detect the CYP2D6 alleles *2, *3, *4, *5, *6, *8, *10 and *14 in 223 subjects from Chinese mainland. Results The CYP2D6* 5 allele was the most frequent poor metabolizer (PM) allele in Chinese (7.2%), followed by CYP2D6* 14 (2.0%) which was only detected in orientals. There was only 0.2% CYP2D6* 4, and no CYP2D6* 3, *6 and *8 were detected. In contrast to the Caucasians, the most frequent allele in Chinese was the *10 allele with a frequency of 51.6%. Conclusion The frequencies of PM alleles, CYP2D6* 5 and CYP2D6*14, were higher; but the frequency of CYP2D6* 10 was lower in mainland Chinese population than that in other orientals.
引用
收藏
页码:1780 / 1784
页数:5
相关论文
共 50 条
  • [1] Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations
    Guangzhao Qi
    Shengju Yin
    Guoliang Zhang
    Xin Wang
    The Pharmacogenomics Journal, 2020, 20 : 114 - 125
  • [2] Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populations
    Qi, Guangzhao
    Yin, Shengju
    Zhang, Guoliang
    Wang, Xin
    PHARMACOGENOMICS JOURNAL, 2020, 20 (01): : 114 - 125
  • [3] RELATIONSHIP OF CYP2D6 GENETIC POLYMORPHISMS AND THE PHARMACOKINETICS OF TRAMADOL IN CHINESE VOLUNTEERS
    Li, Qin
    Zhong, Dafang
    Lou, Jianshi
    Wang, Rui
    DRUG METABOLISM REVIEWS, 2008, 40 : 37 - 37
  • [4] Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers
    Li, Q.
    Wang, R.
    Guo, Y.
    Wen, S.
    Xu, L.
    Wang, S.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (02) : 239 - 247
  • [5] Frequencies of CYP2D6 genetic polymorphisms in Arab populations
    Alali, Mousa
    Al-Khalil, Wouroud Ismail
    Rijjal, Sara
    Al-Salhi, Lana
    Saifo, Maher
    Youssef, Lama A.
    HUMAN GENOMICS, 2022, 16 (01)
  • [6] Frequencies of CYP2D6 genetic polymorphisms in Arab populations
    Mousa Alali
    Wouroud Ismail Al-khalil
    Sara Rijjal
    Lana Al-Salhi
    Maher Saifo
    Lama A. Youssef
    Human Genomics, 16
  • [7] Genetic polymorphisms analysis of CYP2D6 in the Uygur population
    He, Xue
    He, Na
    Ren, Lisong
    Ouyang, Yongri
    Zhang, Ning
    Ma, Yini
    Yuan, Dongya
    Kang, Longli
    Jin, Tianbo
    BMC GENOMICS, 2016, 17
  • [8] Genetic polymorphisms analysis of CYP2D6 in the Uygur population
    Xue He
    Na He
    Lisong Ren
    Yongri Ouyang
    Ning Zhang
    Yini Ma
    Dongya Yuan
    Longli Kang
    Tianbo Jin
    BMC Genomics, 17
  • [9] Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects
    Ophelia Qi Ping Yin
    Valiant Wah Lun Mak
    Miao Hu
    Benny Siu Pong Fok
    Moses Sing Sum Chow
    Brian Tomlinson
    European Journal of Clinical Pharmacology, 2012, 68 : 943 - 949
  • [10] Genetic polymorphism of CYP2D6 in Chinese subjects in Malaysia
    Ismail, R
    Teh, LK
    Amir, J
    Alwi, Z
    Lopez, CG
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (04) : 279 - 284